Company Search:
Advanced Search
Sponsored Links
Oriola Oyj Company Snapshot
Oriola Oyj operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oriola Oyj with three other drug stores in Europe: Neuca SA of Poland (2016 sales of 7.08 billion Polish New Zlotys [US$2.06 billion] of which 99% was Pharmaceutical Wholesale), Udg Healthcare Plc of Ireland (943.08 million Euro [US$1.14 billion] of which 62% was Ashfield), and Selcuk Ecza Deposu Ticaret ve Sanayi AS which is based in Turkey (8.64 billion Turkish Liras [US$2.30 billion] of which 100% was Medical and Hospital Equipment).

Sales Analysis. During the year ended December of 2016, sales at Oriola Oyj were 1.64 billion Euro (US$1.99 billion). This is a very small increase of 1.0% versus 2015, when the company's sales were 1.63 billion Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oriola Oyj
  Stock Performance Chart for Oriola Oyj
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 3.03
(Figures in Euro)
1 Week -0.8%   13 Weeks 6.7%  
4 Weeks -9.8%   52 Weeks -28.9%  
Oriola Oyj Key Data:
  Ticker: OKDBV Country: Finland
  Exchanges: HEL Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2016 Sales 1,642,100,000
(Year Ending Jan 2017).
Employees: 2,821
  Currency: Euro Market Cap: 549,170,505
  Fiscal Yr Ends: December Shares Outstanding: 181,244,391
  Share Type: Osake B Closely Held Shares: 44,197,136
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.